Inappropriate citations used to describe the pharmacology of botulinum toxin type A preparations in clinical use

Author： Zakine Benjamin Pickett Andy M. Maisonobe Pascal

ISSN： 1650-1977

Source： Journal of Rehabilitation Medicine, Vol.41, Iss.7, 2009-06, pp. : 591-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology of therapeutic botulinum toxin preparations

By Dressler Dirk Benecke Reiner

Disability and Rehabilitation, Vol. 29, Iss. 23, 2007-01 ,pp. : 1761-1768

Informa Healthcare

Access to resources Recommend Favorite

Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 3, 2015-08 ,pp. : 202-205

John Wiley & Sons Inc

Access to resources Recommend Favorite

European Consensus Table on the use of Botulinum Toxin Type A in Adult Spasticity

By Wissel Jörg Ward Anthony B. Erztgaard Per Bensmail Djamel Hecht Martin J. Lejeune Thierry M. Schnider Peter

Journal of Rehabilitation Medicine, Vol. 41, Iss. 1, 2009-01 ,pp. : 13-25

Medical Journals Limited

Access to resources Recommend Favorite

USE OF BOTULINUM TOXIN TYPE A IN MANAGEMENT OF ADULT SPASTICITY - A EUROPEAN CONSENSUS STATEMENT

By Ward Anthony B. Aguilar Miguel Beyl Zegers De Gedin Susanne Kanovsky Petr Molteni Franco Wissel Jörg Yakovleff Anton

Journal of Rehabilitation Medicine, Vol. 35, Iss. 2, 2003-01 ,pp. : 98-99

Medical Journals Limited

Access to resources Recommend Favorite

Botulinum toxin type A for treatment of hyperhidrosis

By Nelson Lisa

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 945-953

Future Medicine

Access to resources Recommend Favorite